{"id":"https://openalex.org/W2767015147","doi":null,"title":"Amyloid PET in MCI Patients with Subsyndromal Depressive Symptoms","display_name":"Amyloid PET in MCI Patients with Subsyndromal Depressive Symptoms","publication_year":2015,"publication_date":"2015-05-01","ids":{"openalex":"https://openalex.org/W2767015147","mag":"2767015147"},"language":"en","primary_location":{"id":"mag:2767015147","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/56/supplement_3/525","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047813770","display_name":"Matthias Brendel","orcid":"https://orcid.org/0000-0002-9247-2843","observed_orcids":["https://orcid.org/0000-0002-9247-2843","https://orcid.org/0000-0002-6522-4895"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias Brendel","raw_affiliation_strings":["Department of Nuclear Medicine University of Munich Munich  Germany"],"raw_orcid":"https://orcid.org/0000-0002-9247-2843","affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine University of Munich Munich  Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030969180","display_name":"Julia Sauerbeck","orcid":"https://orcid.org/0000-0002-2256-9164","observed_orcids":["https://orcid.org/0000-0002-2256-9164"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Sauerbeck","raw_affiliation_strings":["Department of Nuclear Medicine University of Munich Munich  Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine University of Munich Munich  Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108610418","display_name":"Andreas Delker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Delker","raw_affiliation_strings":["Department of Nuclear Medicine University of Munich Munich  Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine University of Munich Munich  Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004253128","display_name":"Oliver Michael Pogarell","orcid":"https://orcid.org/0000-0001-6455-4190","observed_orcids":["https://orcid.org/0000-0001-6455-4190"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Pogarell","raw_affiliation_strings":["Department of Psychiatry , University of Munich , Munich, Germany"],"raw_orcid":"https://orcid.org/0000-0001-6455-4190","affiliations":[{"raw_affiliation_string":"Department of Psychiatry , University of Munich , Munich, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037412930","display_name":"Peter Bartenstein","orcid":"https://orcid.org/0009-0005-0734-4994","observed_orcids":["https://orcid.org/0009-0005-0734-4994"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Peter Bartenstein","raw_affiliation_strings":["Department of Nuclear Medicine University of Munich Munich  Germany"],"raw_orcid":"https://orcid.org/0009-0005-0734-4994","affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine University of Munich Munich  Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065710231","display_name":"Axel Rominger","orcid":"https://orcid.org/0000-0002-1954-736X","observed_orcids":["https://orcid.org/0000-0002-1954-736X"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Axel Rominger","raw_affiliation_strings":["Department of Nuclear Medicine University of Munich Munich  Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine University of Munich Munich  Germany","institution_ids":["https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I8204097"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35720993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"56","issue":null,"first_page":"525","last_page":"525"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-pet","display_name":"amyloid PET","score":0.9649999737739563},{"id":"https://openalex.org/keywords/mild-cognitive-impairment","display_name":"mild cognitive impairment","score":0.9120000004768372},{"id":"https://openalex.org/keywords/subsyndromal-depressive-symptoms","display_name":"subsyndromal depressive symptoms","score":0.9610000252723694},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.7099999785423279},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.7450000047683716},{"id":"https://openalex.org/keywords/brain-amyloid-deposition","display_name":"brain amyloid deposition","score":0.7160000205039978},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.5389999747276306},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.75},{"id":"https://openalex.org/keywords/neuropsychiatric-symptoms","display_name":"neuropsychiatric symptoms","score":0.621999979019165},{"id":"https://openalex.org/keywords/amyloid-biomarkers","display_name":"amyloid biomarkers","score":0.3400000035762787}],"concepts":[{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6479827165603638},{"id":"https://openalex.org/C2781357127","wikidata":"https://www.wikidata.org/wiki/Q438896","display_name":"Late life depression","level":3,"score":0.636963963508606},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6058140397071838},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.5734556317329407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5697245597839355},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5381579995155334},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5283349752426147},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.46880701184272766},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4489641487598419},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43610602617263794},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.38151612877845764},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.3380756378173828},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27851659059524536},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.22413387894630432},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.1404111385345459},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2767015147","doi":null,"is_oa":false,"landing_page_url":"https://jnm.snmjournals.org/content/56/supplement_3/525","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2883137360","https://openalex.org/W2041468825","https://openalex.org/W2895913240","https://openalex.org/W2896474589","https://openalex.org/W2617929137","https://openalex.org/W3195929985","https://openalex.org/W3087813289","https://openalex.org/W4403557059","https://openalex.org/W4390193313","https://openalex.org/W4390084568"],"abstract_inverted_index":{"525":[0],"Objectives":[2],"Late":[4],"life":[5],"depression":[6,120],"even":[7],"in":[8,17,31,102,123,130,168,184,203,218,225],"subsyndromal":[9],"stages":[10],"showed":[11],"strong":[12],"associations":[13],"with":[14,118,187],"AD":[15,36],"resulting":[16],"higher":[18,164],"conversion":[19],"rates":[20],"from":[21,35,86],"MCI":[22,67,185,219],"to":[23,57,93,222],"AD.":[24],"Brain":[25],"amyloidosis":[26],"as":[27,73,75],"an":[28],"early":[29],"biomarker":[30],"subjects":[32,68,99],"subsequently":[33],"suffering":[34],"is":[37],"sensitively":[38],"detectable":[39],"by":[40],"amyloid-PET.":[41,193],"Preclinical":[42],"studies":[43],"suggested":[44],"that":[45],"selective-serotonin-reuptake-inhibitors":[46],"(SSRI)":[47],"have":[48],"a":[49,70,76,149,163,191],"beneficial":[50],"influence":[51],"on":[52],"amyloidogenesis.":[53],"Therefore":[54],"we":[55],"aimed":[56],"investigate":[58],"the":[59,87,181,204],"effect":[60,115],"of":[61,198,210],"SSRI":[62,133,139,177,216],"medication.":[63],"Methods":[65],"receiving":[69,132,162],"baseline":[71,156],"[18F]-AV45-PET":[72],"well":[74],"2-year":[77],"follow-up":[78],"(2-y-FU)":[79],"study":[80],"and":[81,90,111,136,190,215],"corresponding":[82],"MRI":[83],"were":[84,100,128],"selected":[85],"ADNI":[88],"database":[89],"stratified":[91],"according":[92],"their":[94],"amyloid":[95,153,199],"status.":[96],"200":[97],"amyloid-positive":[98],"analyzed":[101],"MNI":[103],"space":[104],"after":[105],"MRI-based":[106],"coregistration,":[107],"white":[108],"matter":[109],"scaling":[110],"VOI-based":[112],"partial":[113],"volume":[114],"correction.":[116],"Subjects":[117],"positive":[119,146,192],"item":[121],"(N=54)":[122],"Neuropsychiatric":[124],"Inventory":[125],"Questionnaire":[126],"(NPI-Q)":[127],"subdivided":[129],"patients":[131,137,147,186,220],"medication":[134,178],"(N=20)":[135],"without":[138],"treatment":[140,217],"(N=34).":[141],"Results":[143],"NPI-Q":[145],"had":[148],"moderately":[150],"elevated":[151],"brain":[152],"level":[154],"at":[155],"(SUVR":[157],"0.85":[158],"vs.":[159,171],"0.82,":[160],"p=0.2),":[161],"increase":[165],"(i.e.":[166],"deterioration)":[167],"ADAS":[169],"(+22.6%":[170],"+1.7%,":[172],"p":[173],"Conclusions":[175],"distinctly":[179],"improved":[180],"cognitive":[182,213],"performance":[183],"depressive":[188,211],"symptoms":[189],"A":[194],"trend":[195],"towards":[196],"deceleration":[197],"deposition":[200],"was":[201],"found":[202],"frontal":[205],"cortex.":[206],"The":[207],"pathophysiological":[208],"interaction":[209],"symptoms,":[212],"function":[214],"needs":[221],"be":[223],"investigated":[224],"more":[226],"detail.":[227]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2017-11-10T00:00:00"}